https://syngene-dev.syngeneintl.com/resources/viewpoints/ 2026-07-28T09:57:35+00:00 https://syngene-dev.syngeneintl.com/resources/viewpoints/bile-duct-cannulated-pk-studies-guide/ 2026-03-23T12:36:07+00:00 https://syngene-dev.syngeneintl.com/wp-content/uploads/2025/10/BDC-studies-Viewpoint-Header-1-1.jpg https://syngene-dev.syngeneintl.com/resources/viewpoints/advancing-mab-manufacturing-with-customer-centric-solutions/ 2026-03-23T12:39:28+00:00 https://syngene-dev.syngeneintl.com/wp-content/uploads/2025/09/Advancing-mAb-manufacturing-header.jpg https://syngene-dev.syngeneintl.com/resources/viewpoints/peptides-a-scientific-revolution-in-modern-medicine/ 2026-03-23T12:40:47+00:00 https://syngene-dev.syngeneintl.com/wp-content/uploads/2025/08/GLP-1-Peptides-banner.jpg https://syngene-dev.syngeneintl.com/resources/viewpoints/chemical-derivatization-lc-ms-bioanalysis/ 2026-03-23T12:40:55+00:00 https://syngene-dev.syngeneintl.com/wp-content/uploads/2025/04/Banner_1920x772px-1.jpg https://syngene-dev.syngeneintl.com/resources/viewpoints/long-acting-injectables-development/ 2026-03-23T12:41:08+00:00 https://syngene-dev.syngeneintl.com/wp-content/uploads/2025/04/Banner_1920x772px.jpg https://syngene-dev.syngeneintl.com/resources/viewpoints/proactive-covid-19-testing/ 2026-03-23T12:44:43+00:00 https://syngene-dev.syngeneintl.com/wp-content/uploads/2025/02/Proactive-COVID-19-testing-banner.jpg https://syngene-dev.syngeneintl.com/resources/viewpoints/manufacturing-vaccines-during-covid-19/ 2026-03-23T12:44:51+00:00 https://syngene-dev.syngeneintl.com/wp-content/uploads/2025/02/Manufacturing-vaccines-during-COVID-19-banner.jpg https://syngene-dev.syngeneintl.com/resources/viewpoints/process-related-impurities-detection-biopharma/ 2026-03-23T12:46:16+00:00 https://syngene-dev.syngeneintl.com/wp-content/uploads/2025/01/PoV-on-Detection-and-quantitation-banner.jpg https://syngene-dev.syngeneintl.com/resources/viewpoints/large-molecule-bioanalytical-sample-analysis/ 2026-03-23T12:46:43+00:00 https://syngene-dev.syngeneintl.com/wp-content/uploads/2025/01/Banner_1920x772px.jpg https://syngene-dev.syngeneintl.com/resources/viewpoints/cancer-cell-therapy-car-t-development/ 2026-03-23T12:46:55+00:00 https://syngene-dev.syngeneintl.com/wp-content/uploads/2025/01/Banner_1920x772px-1.jpg https://syngene-dev.syngeneintl.com/resources/viewpoints/high-quality-ipscs-drug-discovery-success/ 2026-03-23T12:47:13+00:00 https://syngene-dev.syngeneintl.com/wp-content/uploads/2024/12/Banner_1920x772px.jpg https://syngene-dev.syngeneintl.com/resources/viewpoints/navigating-a-smarter-race-lead-to-first-in-human-studies/ 2026-04-13T12:53:25+00:00 https://syngene-dev.syngeneintl.com/wp-content/uploads/2025/01/Banner_1920x772px-2.jpg https://syngene-dev.syngeneintl.com/resources/viewpoints/global-clinical-trials-strategic-partnerships/ 2026-04-16T09:43:52+00:00 https://syngene-dev.syngeneintl.com/wp-content/uploads/2026/02/GCT-Article-header.webp https://syngene-dev.syngeneintl.com/resources/viewpoints/toxicity-assessment-methods-computational-toxicology/ 2026-04-24T08:32:41+00:00 https://syngene-dev.syngeneintl.com/wp-content/uploads/2025/01/Banner_1920x772px-3.jpg https://syngene-dev.syngeneintl.com/resources/viewpoints/green-chemistry-in-pharmaceuticals/ 2026-04-25T10:36:50+00:00 https://syngene-dev.syngeneintl.com/wp-content/uploads/2025/02/Green-Chemistry-pov-banner.jpg https://syngene-dev.syngeneintl.com/resources/viewpoints/biopharma-rd-innovation-outsourcing-solutions/ 2026-05-05T09:42:44+00:00 https://syngene-dev.syngeneintl.com/wp-content/uploads/2025/02/The-Dedicated-Center-Outsourcing-banner.jpg https://syngene-dev.syngeneintl.com/resources/viewpoints/preclinical-toxicology-glp-ind-strategy/ 2026-05-05T10:22:29+00:00 https://syngene-dev.syngeneintl.com/wp-content/uploads/2025/02/Banner_1920x772px.jpg https://syngene-dev.syngeneintl.com/resources/viewpoints/bioprocess-intensification-biomanufacturing/ 2026-05-05T11:17:52+00:00 https://syngene-dev.syngeneintl.com/wp-content/uploads/2025/02/Intensified-Biomanufacturing-pov-banner.jpg https://syngene-dev.syngeneintl.com/resources/viewpoints/biologics-cmc-regulatory-biophysics-hos/ 2026-05-06T11:26:26+00:00 https://syngene-dev.syngeneintl.com/wp-content/uploads/2025/01/Regulatory-role-of-Biophysics-in-Biologics-CMC-banner.jpg https://syngene-dev.syngeneintl.com/resources/viewpoints/targeted-protein-degradation-protac-discovery/ 2026-05-28T09:39:32+00:00 https://syngene-dev.syngeneintl.com/wp-content/uploads/2025/02/Accelerating-PROTAC-program-pov-banner.jpg https://syngene-dev.syngeneintl.com/resources/viewpoints/supply-chain-risks-resilience-strategies/ 2026-05-28T09:45:17+00:00 https://syngene-dev.syngeneintl.com/wp-content/uploads/2025/02/Transforming-Supply-Chain-risks-pov-banner.jpg https://syngene-dev.syngeneintl.com/resources/viewpoints/dmpk-drug-development-strategies/ 2026-06-02T06:40:56+00:00 https://syngene-dev.syngeneintl.com/wp-content/uploads/2025/01/DMPK-strategies-to-avoid-drug-development-mistakes-early-banner.jpg https://syngene-dev.syngeneintl.com/resources/viewpoints/bispecific-antibodies-clinical-development/ 2026-06-05T09:38:47+00:00 https://syngene-dev.syngeneintl.com/wp-content/uploads/2026/06/Clinical-Development-Header.webp https://syngene-dev.syngeneintl.com/resources/viewpoints/combating-covid19-oligonucleotide-therapeutics/ 2026-06-05T12:42:30+00:00 https://syngene-dev.syngeneintl.com/wp-content/uploads/2025/02/Combating-COVID-19-The-Oligonucleotide-Way-Banner.jpg https://syngene-dev.syngeneintl.com/resources/viewpoints/choosing-right-cro-and-cdmo-biopharma/ 2026-06-05T12:54:19+00:00 https://syngene-dev.syngeneintl.com/wp-content/uploads/2025/01/CRO-CDMO-in-Biopharma-banner.jpg https://syngene-dev.syngeneintl.com/resources/viewpoints/in-vivo-safety-studies-ind-enabling/ 2026-06-05T13:14:23+00:00 https://syngene-dev.syngeneintl.com/wp-content/uploads/2025/01/Safety-Tox-studies-pov-banner.jpg https://syngene-dev.syngeneintl.com/resources/viewpoints/virtual-audit-remote-inspection-compliance/ 2026-06-05T15:20:01+00:00 https://syngene-dev.syngeneintl.com/wp-content/uploads/2025/02/Audit-Syngene-Virtually-banner.jpg https://syngene-dev.syngeneintl.com/resources/viewpoints/early-target-assessment-drug-discovery-success/ 2026-06-19T06:19:31+00:00 https://syngene-dev.syngeneintl.com/wp-content/uploads/2025/01/Enabling-early-assessment-pov-banner.jpg https://syngene-dev.syngeneintl.com/resources/viewpoints/cmc-strategy-small-molecule-development/ 2026-06-25T07:35:47+00:00 https://syngene-dev.syngeneintl.com/wp-content/uploads/2025/02/Integrated-CMC-pov-banner.jpg https://syngene-dev.syngeneintl.com/resources/viewpoints/rise-of-the-indian-cro-cdmo-from-cost-arbitrage-to-innovation-leadership/ 2026-07-13T10:58:49+00:00 https://syngene-dev.syngeneintl.com/wp-content/uploads/2025/09/Rise-of-the-Indian-CRO-CDMO-Homepage-header.jpg https://syngene-dev.syngeneintl.com/resources/viewpoints/ai-crdmos/ 2026-07-13T11:11:36+00:00 https://syngene-dev.syngeneintl.com/wp-content/uploads/2026/01/Figure-2-1-scaled.webp https://syngene-dev.syngeneintl.com/resources/viewpoints/biologics-technology-transfer-manufacturing/ 2026-07-28T08:40:02+00:00 https://syngene-dev.syngeneintl.com/wp-content/uploads/2025/02/Achieving-Biologics-manufacturing-milestones-banner.jpg https://syngene-dev.syngeneintl.com/resources/viewpoints/antisense-oligonucleotide-manufacturing-drug-development/ 2026-07-28T09:57:35+00:00 https://syngene-dev.syngeneintl.com/wp-content/uploads/2025/02/Antisense-Oligonucleotides-pov-banner.jpg